MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks

Orthofix wins FDA PMA nod for M6-C artificial cervical disc

February 8, 2019 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) said yesterday that it won FDA approval for its M6-C artificial cervical disc, intended for treating patients suffering from cervical disc degeneration. The Lewisville, Texas-based company said that the M6-C artificial cervical disc was developed by Spinal Kinetics, which it acquired last April. The newly cleared M6-C is a next-gen artificial disc intended to replace […]

Filed Under: Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Spinal Tagged With: Orthofix

Orthofix acquires distributor Options Medical

February 4, 2019 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) said today that it acquired Florida-based medical device distributor Options Medical for an undisclosed amount. As part of deal, Lewisville, Texas-based Orthofix said that all employees of Options Medical were transitioned with the buy, which became effective February 1. “Options Medical started in North Central Florida as a small team of hard working individuals […]

Filed Under: Distribution, Featured, Mergers & Acquisitions Tagged With: Orthofix

Boston Scientific shares tick up after Q4 prelims meet estimates | Wall Street Beat

January 8, 2019 By Sarah Faulkner Leave a Comment

Shares in Boston Scientific (NYSE:BSX) rose slightly this morning after the company reported preliminary results for the fourth quarter and full year of 2018 that were in-line with estimates on Wall Street. The Marlborough, Mass.-based company said it expects to report $2.56 billion in sales for the fourth quarter and $9.82 billion for the full year. […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Alphatec, Boston Scientific, Hologic, ICON plc, Integra LifeSciences, NovoCure, Orthofix, SeaSpine

Orthofix Q3 beats The Street

October 29, 2018 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) today posted third quarter earnings that topped both sales and earnings per share expectations on Wall Street. The Lewisville, Texas-based company posted losses of $1.2 million, or 7¢ per share, on sales of $111.7 million for the three months ended September 30, seeing a 135% swing into the red while sales grew 6.1% compared […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Orthofix

Orthofix Q2 shows shrinking profits

August 9, 2018 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) this week posted second quarter earnings that beat expectations on Wall Street but showed growing losses. The Lewisville, Texas-based company posted profits of $925,000, or 5¢ per share, on sales of $111.6 million for the three months ended June 30, seeing profits shrink 97.6% while sales grew 2.4% compared with the same period last […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Orthofix

Orthofix to become Orthofix Medical after Delaware reincorporation

July 19, 2018 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) is changing its official name to Orthofix Medical after shifting the jurisdiction of the company from Curaçao to the state of Delaware, according to a recently posted SEC filing. The company said that it will continue to trade under the symbol “OFIX” and that there will be no changes to its shares, according to the […]

Filed Under: Business/Financial News Tagged With: Orthofix

Orthofix pivots to spine, extremities

June 26, 2018 By Brad Perriello Leave a Comment

Orthofix (NSDQ:OFIX) said yesterday that it’s planning a pivot to the spine and extremities market beginning next year, folding its biostim and biologics businesses back into the spine segment five years after it split them out in the first place. In July 2013 Lewisville, Texas-based Orthofix split the spine segment into biostim and spine fixation divisions, promoting Brad Niemann […]

Filed Under: Orthopedics, Wall Street Beat Tagged With: Orthofix

Orthofix closes $105m Spinal Kinetics buyout, cuts earnings outlook

May 1, 2018 By Brad Perriello Leave a Comment

Orthofix (NSDQ:OFIX) said yesterday that it closed the $105 million buyout of Spinal Kinetics and its M6 cervical disc implant, but cut its earnings outlook for the rest of the year despite higher-than-expected first-quarter results. The deal for Sunnyvale, Calif.-based Spinal Kinetics called for $45 million in up-front cash, plus another $65 million in milestones pegged to FDA approval of […]

Filed Under: MassDevice Earnings Roundup, Mergers & Acquisitions, Orthopedics, Spinal, Wall Street Beat Tagged With: Orthofix, Spinal Kinetics

Orthofix puts $105m on the table for Spinal Kinetics

March 16, 2018 By Brad Perriello Leave a Comment

Orthofix (NSDQ:OFIX) said yesterday that it put up to $105 million on the table to acquire Spinal Kinetics and its M6 cervical disc implant. Lewisville, Texas-based Orthofix said the deal calls for $45 million in up-front cash, plus another $65 million in milestones pegged to FDA approval of the M6 cervical device and trailing twelve-month sales targets […]

Filed Under: Mergers & Acquisitions, Orthopedics, Spinal, Wall Street Beat Tagged With: Orthofix, Spinal Kinetics

Orthofix wins FDA, CE Mark for next-gen PhysioStim bone-growth stimulator

March 7, 2018 By Fink Densford Leave a Comment

Orthofix (NSDQ:OFIX) said today it won FDA approval in the US and CE Mark approval in the European Union for its next-gen PhysioStim bone growth stimulator devices. The device is designed as a non-surgical treatment option for patients with a nonunion fracture in an extremity with no visible signs of healing, using pulsed electromagnetic field signals to […]

Filed Under: 510(k), Orthopedics, Regulatory/Compliance Tagged With: Orthofix

Orthofix swings to Q4 black

February 27, 2018 By Brad Perriello Leave a Comment

Orthofix (NSDQ:OFIX) yesterday put black ink in the ledger for the fourth quarter and beat the consensus forecast as it contemplates moving its corporate registration from Curacao to the U.S. The Lewisville, Texas-based orthopedics company posted profits of $1.6 million, or 8¢ per share, on sales of $116.9 million for the three months ended Dec. 31, 2017, […]

Filed Under: MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: Orthofix

  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS